Literature DB >> 2873807

Postherpetic neuralgia. A review.

P N Watson, R J Evans.   

Abstract

Postherpetic pain persisting one month or longer occurs in 9% to 14% of patients with herpes zoster, diminishing with time. The incidence and duration are directly related to age. The pathologic features have been described but the pathogenesis of postherpetic neuralgia is unknown. Treatment remains difficult. It is reasonable to hope for a reduction in pain from severe to mild in two of three cases. There is evidence to support the use of low doses of tricyclic antidepressants, especially amitriptyline hydrochloride, with gradual small increments, and also the use of phenothiazines. Corticosteroids may exert a preventive effect when used in the acute phase. There is some support for the use of local physical modalities. Neurosurgical procedures are a possibility in failed medical cases. Controlled studies of newer approaches are necessary.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2873807     DOI: 10.1001/archneur.1986.00520080074027

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  12 in total

1.  Varicella-zoster virus productively infects mature dendritic cells and alters their immune function.

Authors:  Gavin Morrow; Barry Slobedman; Anthony L Cunningham; Allison Abendroth
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

2.  Somatosensory findings in postherpetic neuralgia.

Authors:  T Nurmikko; D Bowsher
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-02       Impact factor: 10.154

Review 3.  Optimal treatment of phantom limb pain in the elderly.

Authors:  R Baron; G Wasner; V Lindner
Journal:  Drugs Aging       Date:  1998-05       Impact factor: 3.923

4.  Characterization of the host immune response in human Ganglia after herpes zoster.

Authors:  Kavitha Gowrishankar; Megan Steain; Anthony L Cunningham; Michael Rodriguez; Peter Blumbergs; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

5.  Productive varicella-zoster virus infection of cultured intact human ganglia.

Authors:  Kavitha Gowrishankar; Barry Slobedman; Anthony L Cunningham; Monica Miranda-Saksena; Ross A Boadle; Allison Abendroth
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

6.  Antigen detection: the method of choice in comparison with virus isolation and serology for laboratory diagnosis of herpes zoster in human immunodeficiency virus-infected patients.

Authors:  H Dahl; J Marcoccia; A Linde
Journal:  J Clin Microbiol       Date:  1997-02       Impact factor: 5.948

7.  [Pain therapy in herpes zoster and post-zoster neuralgia.].

Authors:  T Zenz; M Zenz; M Tryba
Journal:  Schmerz       Date:  1994-03       Impact factor: 1.107

8.  Varicella-zoster virus glycoprotein I is essential for spread in dorsal root ganglia and facilitates axonal localization of structural virion components in neuronal cultures.

Authors:  Jenna Christensen; Megan Steain; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

Review 9.  Amitriptyline. A review of its pharmacological properties and therapeutic use in chronic pain states.

Authors:  H M Bryson; M I Wilde
Journal:  Drugs Aging       Date:  1996-06       Impact factor: 3.923

10.  Herpes zoster: a clinical study in 205 patients.

Authors:  E N Abdul Latheef; K Pavithran
Journal:  Indian J Dermatol       Date:  2011 Sep-Oct       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.